Drugging Undruggable Transcription Factor Drivers In Cancer

Drugging “undruggable” transcription factor drivers in cancer

Drugging the Undruggable Cancer Targets

Rick Young "Drugging Transcription"

KochInstituteMIT

Molecular glues: drugging the ”undruggable”

Vetenskapsakademien

Dan Nomura - Dana-Farber Targeted Degradation Webinar Series

Dana-Farber TPD

Hannan (2015): The emergence of transcription factors as therapeutic tools for cancer therapy

European Journal Prize Lecture: Jason Carroll

European Society of Endocrinology

Public Lecture: Drugging an Undruggable Target — with Dr Nick Tonks

Cold Spring Harbor Laboratory

Genetics Seminar Series 2020: Richard Young, PhD

At the Crossroads of Epigenetics and Angiogenesis Targeting the Undruggable

UT Southwestern Medical Center

Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras

Paper Breakdown: How to identify new molecular glue degraders

The Friedrich Miescher Institute for Biomedical Research

Intra-Tumor Heterogeneity and Drug Response

OHSU Informatics

CSHL Keynote, Dr, Richard Young, Whitehead Institute/M.I.T.

CSHL Leading Strand

PhoreMost - Drugging the Undruggable ®

Rajesh Chopra - Dana-Farber Targeted Degradation Webinar Series

Dana-Farber TPD

5.5 Drugable or undrugable targets

Drugging the Undruggable: Targeted Protein Degradation as Medicine - 5 April 2022

Translating the Cancer Genome: A Drug Discovery Perspective

RCMI Program UPR Medical Sciences Campus

Targeting Transcriptional Addiction in High-risk Pediatric Cancers

CU Cancer Center